Insulin resistance and increased leptin concentrations in noncompliant schizophrenia patients but not in antipsychotic-naive first-episode schizophrenia patients

Journal of Clinical Psychiatry

Volumn 65, Issue 10, 2004, Pages 1335-1342

  Arranz, Belén ^a   Rosel, Pilar ^b   Ramírez, Nicolas ^a   Dueñas, Rosa ^a   Ferńndez, Paloma ^a   Sanchez, Jose María ^a   Navarro, Miguel Angel ^b   San, Luis ^a  

^a HOSPITAL GENERAL DE GRANOLLERS   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN; LEPTIN; NEUROLEPTIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; BODY MASS; COMPARATIVE STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; MALE; METABOLISM; MIDDLE AGED; PSYCHOLOGICAL RATING SCALE; SCHIZOPHRENIA; TREATMENT REFUSAL;

ADOLESCENT; ADULT; AGED; ANTIPSYCHOTIC AGENTS; BLOOD GLUCOSE; BODY MASS INDEX; C-PEPTIDE; FEMALE; GLUCOSE; HUMANS; INSULIN; INSULIN RESISTANCE; LEPTIN; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; TREATMENT REFUSAL;

EID: 16544377948     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v65n1007     Document Type: Article

References (37)

1. Mohan D, Gordon H, Hindley N, et al. Schizophrenia and diabetes mellitus [letter]. Br J Psychiatry 1999;174:180-181
2. Hägg S, Joelsson L, Mjörndal T, et al. Prevalence of diabetes and impaired glucose tolerance in patients treated with clozapine compared with patients treated with conventional depot neuroleptic medications. J Clin Psychiatry 1998;59:294-299 (Pubitemid 28353977)
3. Melkersson KI, Hulting A-L, Brismar KE. Elevated levels of insulin, leptin, and blood lipids in olanzapine-treated patients with schizophrenia or related psychosis. J Clin Psychiatry 2000;61:742-749 (Pubitemid 30809944)
4. Melkersson KI, Hulting A-L. Insulin and leptin in patients with schizophrenia or related psychoses: a comparison between different antipsychotic agents. Psychopharmacology (Berl) 2001;154:205-212 (Pubitemid 32186506)
5. Sernyak MJ, Leslie DL, Alarcon RD, et al. Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia. Am J Psychiatry 2002;159:561-566 (Pubitemid 34274937)
6. Wirshing DA, Boyd JA, Meng LR, et al. The effects of novel antipsychotics on glucose and lipid levels. J Clin Psychiatry 2002;63:856-865 (Pubitemid 35231725)
7. Atmaca M, Kuloglu M, Tezcan E, et al. Weight gain, serum leptin and triglyceride levels in patients with schizophrenia on antipsychotic treatment with quetiapine, olanzapine and haloperidol [letter]. Schizophr Res 2003;60:99-100 (Pubitemid 36015794)
8. Brambilla F, Guastalla A, Guerrini A, et al. Glucose-insulin metabolism in chronic schizophrenia. Dis Nerv Syst 1976;37:98-103
9. Dixon L, Weiden P, Delahanty J, et al. Prevalence and correlates of diabetes in national schizophrenia samples. Schizophr Bull 2000;26: 903-912 (Pubitemid 30809169)
10. Mukherjee S, Schnur DB, Reddy R. Family history of type 2 diabetes in schizophrenic patients [letter]. Lancet 1989;1:495 (Pubitemid 19063553)
11. Allison DB, Mentore JL, Heo M, et al. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 1999;156: 1686-1696 (Pubitemid 29517559)
12. Fleischhacker WW, Meise U, Gunther V. Compliance with antipsychotic drug treatment: influence of side effects. Acta Psychiatr Scand Suppl 1994;382:11-15 (Pubitemid 24199707)
13. Baptista T, Lacruz A, DeMendoza S. Body weight gain after administration of antipsychotic drugs: correlation with leptin, insulin and reproductive hormones. Pharmacopsychiatry 2000;33:81-88 (Pubitemid 30346135)
14. Baptista T, Lacruz A, Angeles F, et al. Endocrine and metabolic profile involved in the obesity associated with typical antipsychotic drug administration. Pharmacopsychiatry 2001;34:223-231 (Pubitemid 33086855)
15. Baptista T, Beaulieu S. Are leptin and cytokines involved in body weight gain during treatment with antipsychotic drugs? Can J Psychiatry 2002; 47:742-749
16. Herran A, García-Unzueta MT, Amado JA, et al. Effects of long-term treatment with antipsychotics on serum leptin levels. Br J Psychiatry 2001;179:59-62 (Pubitemid 32625998)
17. Harris RBS. Leptin: much more than a satiety signal. Annu Rev Nutr 2000;20:45-75 (Pubitemid 30707974)
18. Ahren B, Larsson H, Wilhelmsson C. Regulation of circulating leptin in humans. Endocrine 1997;7:1-8 (Pubitemid 127483079)
19. Hägg S, Söderberg S, Ahrén B, et al. Leptin concentrations are increased in subjects treated with clozapine or conventional antipsychotics. J Clin Psychiatry 2001;62:843-848 (Pubitemid 33131169)
20. Kraus T, Haack M, Schuld A, et al. Body weight and leptin plasma levels during treatment with antipsychotic drugs. Am J Psychiatry 1999;156: 312-314 (Pubitemid 29077125)
21. Must A, Spadano J, Coakley EH. The disease burden associated with overweight and obesity. JAMA 1999;282:1523-1529 (Pubitemid 29504045)
22. Ma Z, Gingerich RL, Santiago JV. Radioimmunoassay of leptin in human plasma. Clin Chem 1996;42:942-946 (Pubitemid 126664249)
23. Mathews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28: 412-419 (Pubitemid 15018832)
24. Melkersson KI, Hulting A-L, Brismar KE. Different influences of classical antipsychotics and clozapine on glucose-insulin homeostasis in patients with schizophrenia or related psychoses. J Clin Psychiatry 1999;60:783-791
25. Ryan M, Collins P, Thakore JH. Impaired fasting glucose tolerance in first-episode drug-naive patients with schizophrenia. Am J Psychiatry 2003;160:284-289 (Pubitemid 41110453)
26. Mukherjee S, Decina P, Bocola V, et al. Diabetes mellitus in schizophrenic patients. Compr Psychiatry 1996;37:68-73 (Pubitemid 26024880)
27. Lindenmayer JP, Czobor P, Volavka J, et al. Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics. Am J Psychiatry 2003;160:290-296 (Pubitemid 41110454)
28. Meyer JM. A retrospective comparison of weight, lipid, and glucose changes between risperidone- and olanzapine-treated inpatients: metabolic outcomes after 1 year. J Clin Psychiatry 2002;63:425-433 (Pubitemid 34507221)
29. Cohen J. Statistical Power Analysis for the Behavioral Sciences. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988
30. Weyer C, Bogardus C, Mott DM. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 1999;104:787-794 (Pubitemid 29536364)
31. + channel. Eur J Pharmacol 1991;198:101-104
32. Wozniak M, Rydzewski B, Baker SP. The cellular and physiological actions of insulin in the central nervous system. Neurochem Int 1993;22:1-10 (Pubitemid 23024678)
33. Meguid MM, Fetissov SO, Varma M, et al. Hypothalamic dopamine and serotonin in the regulation of food intake. Nutrition 2000;16:843-857 (Pubitemid 30777338)
34. Rosenbaum M, Nicolson M, Hirsch J. Effects of gender, body composition and menopause on plasma concentrations of leptin. J Clin Endocrinol Metab 1996;81:3424-3427 (Pubitemid 26296228)
35. Kolaczynski JW, Nyce MR, Considine RV. Acute and chronic effect of insulin on leptin production in humans: studies in vitro and in vivo. Diabetes 1996;45:699-701 (Pubitemid 26142812)
36. Tanizawa Y, Okuya S, Ishihara H. Direct stimulation of basal insulin secretion by physiological concentrations of leptin in pancreatic beta cells. Endocrinology 1997;138:4513-4516 (Pubitemid 27408506)
37. Lebovitz HE. Insulin resistance: definition and consequences. Exp Clin Endocrinol Diabetes 2001;109(suppl 2):S135-S148 (Pubitemid 32577577)